Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

In Ireland, WuXi Biologics has sold a new vaccine plant to Merck & Co. for €500 million ($521 million). The New Jersey company was a natural buyer of the facility as it was the lone client WuXi ...

Moderna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) cancer vaccines. This expansion of their 2016 collaboration will ...

Over 3,000 people are employed across the network. Merck and WuXi Vaccines are now entering a formal handover process, expected to conclude in the first half of 2025. Once complete, the facility ...

The lawsuit, filed by the firm Wisner Baum — for which Kennedy has served as a consultant — represents clients who claim to have been harmed by the vaccine. (Merck maintains that the ...

These vaccines are all effective against rabies virus, though there are slight differences between vaccines. Nobivac (Merck Animal Health), Vanguard (Zoetis), Rabvac (Elanco), and Imrab ...

Other high-profile medications have included diabetes treatments and anti-HIV drugs. Merck produces vaccines and has a large animal medicine business as well as a services segment whose offerings ...

Hesitancy around vaccines has spilled over to pet owners in recent years, sparking concern about the resurgence of rabies, a ...

Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "Rabies Veterinary Vaccines Market Size, Share & Trends Analysis by Application and Region, 2025-2030" report has been added to ResearchAndMarkets.com ...

Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "Rabies Veterinary Vaccines Market Size, Share & Trends Analysis by Application and Region, 2025-2030" report has been added to ResearchAndMarkets.com's ...